Significance of early aminotransferase elevation after liver transplantation

Transplantation

Volumn 65, Issue 1, 1998, Pages 68-72

  Rosen, Hugo R ^a,b   Martin, Paul ^a   Goss, John ^a   Donovan, John ^a,c   Melinek, Judy ^a   Rudich, Steve ^a   Imagawa, David K ^a   Kinkhabwala, Milan ^a   Seu, Philip ^a   Busuttil, Ronald W ^a   Shackleton, Christopher R ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Hepatology Section   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIAGNOSTIC VALUE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INFANT; LIVER FUNCTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ASPARTATE AMINOTRANSFERASES; BILIARY TRACT; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; MUROMONAB-CD3; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 0031887802     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801150-00013     Document Type: Article

References (31)

1. Shackleton CR, Martin P, Melinek J, et al. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. Transplantation 1995; 60: 554.
2. Fisher A, Miller CM. Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited? Hepatology 1995; 21: 589.
3. Hardy KJ, Tancheroen S, Shulkes A. Hepatic ischemia-reperfusion injury modification during liver surgery in rats: pretreatment with nifedipine or misoprostol. Liver Transplant Surg 1995; 1: 302.
4. Chazouilleres O, Calmus Y, Vaubourdolle M, Ballet F. Preservation-induced liver injury: clinical aspects, mechanisms and therapeutic approaches. J Hepatol 1993; 18: 123.
5. UNOS. Annual report of the U.S. Scientific Registry for Transplant Recipients and Organ Procurement and Transplantation Network: transplant data 1988-1993. UNOS, Richmond, VA: UNOS and Bethesda, MD: Division of Organ Transplantation, Bureau of Health Resource Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, 1994.
6. Marsman MA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246.
7. Deschenes M, Belle S, Roberts JP, Lake JR, and the LTD Steering Committee. Development and testing of a predictive model for early allograft dysfunction after liver transplantation. Hepatology 1996; 24: 181A.
8. Ploeg RJ, D'Alessandro AM, Knechtle SJ. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55: 807.
9. Snover DC. The pathology of acute rejection. Transplant Proc 1986; 18 (Suppl 4): 123.
10. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histological and immunological features. Hepatology 1991; 13: 882.
11. Greig PD, Woolf H, Sinclair SB, et al. Treatment of primary liver graft nonfunction with prostaglandin El. Transplantation 1989; 48: 447.
12. Nishimura T, Yoshida Y, Watanabe F, Koseki M, Nishida T. Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver. Hepatology 1986; 6: 701.
13. Coletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion in the rat. J Clin Invest 1990; 85: 1936.
14. Jaeschke H, Farhood A. Neutrophil and Kupffer self-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: 355G.
15. Nakamura S, Nishiyama R, Serizawa A, et al. Hepatic release of endothelin-1 after warm ischemia. Transplantation 1995; 59: 679.
16. Howard TK, Klintmalm GTG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103.
17. Leon MP, Bassendine MF, Gibbs P, Burt AD, Thick M, Kirby JA. Hepatic allograft rejection: regulation of the immunogenecity of human intrahepatic biliary epithelial cells. Liver Transplant Surg 1996; 2: 37.
18. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
19. Shackleton CR, Ettinger SL, McLoughlin MG, et al. Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation 1990; 49: 641.
20. Katz E, Mor E, Patel T, et al. Association between preservation injury and early rejection in clinical liver transplantation: myth or fact. Transplant Proc 1993; 25: 1907.
21. Adams D. Mechanisms of liver allograft rejection in man. Clin Sci 1990; 78: 343.
22. Weisner RH, Ludwig J, Van Hoek B, Krom RAF. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14: 721.
23. Porayko MK, Kondo M, Steers JL. Liver transplantation: late complications of the biliary tract and their management. Semin Liver Dis 1995; 15: 139.
24. Noah K, Bronk SF, Kato A, Gores GI. Bile duct cells are more vulnerable to re-oxygenation injury than anoxia. Transplantation 1993; 56: 495.
25. Desmet VJ. Vanishing bile duct disorders. Prog Liver Dis 1992; X: 89.
26. Clavien P-A, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: overview and synthesis of current studies. Transplantation 1992; 53: 957.
27. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49.
28. Kadmon M, Bleyl J, Kuppers B, Otto G, Herfath C. Biliary complications after prolonged University of Wisconsin preservation of liver allografts. Transplant Proc 1993; 25: 1651.
29. Sankary HN, McChesney L, Hart M, Foster P, Williams J. Identification of donor and recipient risk factors associated with nonanastamotic biliary strictures in human hepatic allografts. Transplant Proc 1993; 25: 1964.
30. Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transplant Surg 1995; 1: 296.
31. Vallera RA, Cotton PB, Clavien P-A. Biliary reconstruction for liver transplantation and management of biliary complications: overview and survey of current practices ha the United States. Liver Transplant Surg 1995; 1: 143.